[go: up one dir, main page]

NZ335999A - Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells - Google Patents

Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells

Info

Publication number
NZ335999A
NZ335999A NZ335999A NZ33599996A NZ335999A NZ 335999 A NZ335999 A NZ 335999A NZ 335999 A NZ335999 A NZ 335999A NZ 33599996 A NZ33599996 A NZ 33599996A NZ 335999 A NZ335999 A NZ 335999A
Authority
NZ
New Zealand
Prior art keywords
yeast
composition
treatment
vaginal
inhibitory agent
Prior art date
Application number
NZ335999A
Inventor
Mark S Reinhard
Byron T Burlingham
Original Assignee
Mark S Reinhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark S Reinhard filed Critical Mark S Reinhard
Priority to NZ335999A priority Critical patent/NZ335999A/en
Priority claimed from PCT/US1996/017797 external-priority patent/WO1998019545A1/en
Publication of NZ335999A publication Critical patent/NZ335999A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A composition for the treatment of vaginal yeast which promotes normal vaginal bacterial growth during treatment, comprising a yeast-inhibitory agent selected from one or more of the group consisting of ethylene glycol, propylene glycol, and glycerol, an effectively buffered aqueous acetate solution and cells of a Lactobacillus species. In the composition the concentration of acetate is effective to establish a pH of the composition in the range of from about 5 to about 7, the presence of unionized acetate inhibits yeast selectively compared to the bacteria, and the proportions of the yeast inhibitory agent and the buffering solution are effective to allow the active yeast-inhibitory agent to inhibit the vaginal yeast Candida.
NZ335999A 1996-11-06 1996-11-06 Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells NZ335999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ335999A NZ335999A (en) 1996-11-06 1996-11-06 Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/017797 WO1998019545A1 (en) 1991-02-19 1996-11-06 Composition and method for the treatment of vaginal yeast infections
NZ335999A NZ335999A (en) 1996-11-06 1996-11-06 Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells

Publications (1)

Publication Number Publication Date
NZ335999A true NZ335999A (en) 2000-12-22

Family

ID=26652063

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335999A NZ335999A (en) 1996-11-06 1996-11-06 Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells

Country Status (1)

Country Link
NZ (1) NZ335999A (en)

Similar Documents

Publication Publication Date Title
CA2320040A1 (en) Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
NZ513835A (en) Methods for using vaginal lactobacillus
NZ335521A (en) Bacillus thuringiensis strain AQ52 for controlling antimicrobial activity against fungi and bacteria
WO2001040441A3 (en) Treatment of seeds and plants with useful bacteria
PL324454A1 (en) Inhibition of bacteria growth in absorptive articles by addition of other bacteria
ATE482712T1 (en) MESENCHYMAL STEM CELL SUPERNATANTS FOR PREVENTING AND TREATING IMMUNE RESPONSE IN TRANSPLANTATIONS
WO2001051066A3 (en) Reduction in bacterial colonization by administering bacteriophage compositions
AU5310298A (en) A method for enzymatic treatment of biofilm
AU8030791A (en) Compositions having improved antibacterial properties and use of such compositions in suppressing growth of micro-organisms, e.g. listeria bacteria
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
EP0154478A3 (en) Bacterial preparations and their use
ATE294852T1 (en) MUTIENZYME COMPOSITION WITH GLUCOAMYLASE, PROTEASE AND XYLANASE ACTIVITY, AND METHOD FOR THE PRODUCTION THEREOF BY ASPERGILLUS FERMENTATION IN SOLID GRAIN WHEAT MEDIUM
CA2246273A1 (en) Microorganisms and their use in treating animal feed and silage
ES2014534A6 (en) BACTERIAL TREATMENT METHOD OF HAY.
NO983097L (en) Nisin in combination with glycerol monolaurate which is active against Helicobacter
EP0889690A4 (en) ANTIBIOTICS COCKTAIL AND METHOD OF USE
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
Thomas et al. Studies on the mechanism of the sporicidal action of glutaraldehyde
EP1060745A3 (en) A composition and method for treating bacterial infection
EP1745790A3 (en) Treatment of rumen acidosis with alpha-amylase inhibitors
NZ335999A (en) Composition and method for the treatment of vaginal yeast infections comprising lactobacillus cells
WO2002020726A3 (en) Method for increasing the effectiveness of antiinfective agents
CA2394938A1 (en) Glyoxalase i for reducing carbonyl compounds in carbonyl stress
WO2004060272A3 (en) Delivery of peroxide-generating enzymes to the vaginal tract
BR0009636A (en) Preparation of pancreatic procarboxypeptidase b, iso and mutein forms thereof and their use

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)